Related Experiment Video
Updated: Jun 21, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
Tumor-suppressive microRNAs in Lung cancer: diagnostic and therapeutic opportunities
Lorenzo F Sempere1, Xi Liu, Ethan Dmitrovsky
1Department of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA. Lorenzo.F.Sempere@Dartmouth.EDU
Abstract:
Lung cancer is the leading cause of cancer-related death for both men and women in the U.S. As for many other cancer types, lung cancer is not a single disease, but rather a variety of diseases that present different histopathological, molecular and clinical characteristics. Improved diagnostic and therapeutic tools are needed to manage and treat lung cancer patients. microRNAs are a recently discovered class of short, noncoding RNAs that constitute a novel and functionally important layer of gene regulation. Using new mouse transgenic models for lung cancer, Liu and colleagues reported a genome-wide microRNA expression analysis and identified a signature of down-regulated microRNAs in lung cancer tissues relative to adjacent normal lung. This signature was validated in clinical specimens from lung cancer patients, underscoring the relevance of this profile to human lung cancer. In vitro experiments demonstrated that restoring miR-34c, miR-145, or miR-142-5p expression markedly diminished proliferation of lung cancer cell lines. Here, we discuss the clinical implications of these findings for lung cancer biology, therapy, and prevention.
Insights
Researchers identified a signature of down-regulated microRNAs in lung cancer, crucial for understanding cancer biology and developing new therapies. Restoring specific microRNAs inhibited lung cancer cell proliferation.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Lung cancer is a leading cause of cancer death, characterized by diverse molecular and clinical features.
- microRNAs (miRNAs) are short, noncoding RNAs regulating gene expression and are implicated in various diseases.
- Improved diagnostic and therapeutic strategies are essential for effective lung cancer management.
Purpose of the Study:
- To identify microRNA expression profiles in lung cancer.
- To investigate the role of specific microRNAs in lung cancer cell proliferation.
- To explore the clinical implications of microRNA dysregulation in lung cancer.
Main Methods:
- Genome-wide microRNA expression analysis in mouse transgenic lung cancer models.
- Validation of microRNA signatures in clinical specimens from lung cancer patients.
- In vitro experiments assessing the impact of restoring specific microRNA expression on cancer cell proliferation.
Main Results:
- A distinct signature of down-regulated microRNAs was identified in lung cancer tissues compared to normal lung tissue.
- This microRNA signature was validated in human lung cancer specimens.
- Restoring expression of miR-34c, miR-145, or miR-142-5p significantly reduced lung cancer cell proliferation in vitro.
Conclusions:
- Dysregulated microRNAs play a significant role in lung cancer development and progression.
- The identified microRNA signature holds potential for diagnostic and therapeutic applications in lung cancer.
- Targeted restoration of specific microRNAs may offer a novel strategy for lung cancer treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs
